قائمة أبحاثي

1.   Fexofenadine in Childbearing Age and Early Pregnancy.  Anas Almarzouki, Amal S. Shobokshi, Nawal AlSenani and Khalid Sait.  Med. J. Cairo Univ. Vol 77, No.2, December: 183-186, 2009.

 

2.  An Alternative to Hysterectomy. Abdulrahim A. Rouzi, Nora N. Sahly, Amal S. Shobokshi and Hassan S. Abduljabbar.  Saudi Med. J. 2009; Vol.30, (11): 1473-1475.

 

3.    Operative laparoscopy for the treatment of large ovarian dermoid cyst. Nora N. Sahly, Sharifa A. Alsibiani, Amal S. Shobokshi and
Abdulrahim A. Rouzi. Middle East Fertility Society Journal, Vol.14, No.1, 2009.

 

4.  Audit of Cord Prolapse Management at King Abdulaziz University Hospital. Anas M. Almarzouki and Amal S. Shobokshi. JKAU: Med. Sci.Vol. 16, No.2, pp:35-42(2009 A.D./ 1430 A.H.)”.  Saudi Med. J. 2009; Vol.30, (11): 1473-1475.


5.  Choice of Reliable Biomarkers for Ovarian Aging. Amal S. Shobokshi. Arab J. Clin. Invest. (2004). Vol. 1. 1: 73-81

 

6. Clinical Imperative to Test for Macroprolactin Contribution of Macroprolactinemia to Misdiagnosis and Mismanagement of Pathological Hyperprolactinemia”. Amal S. Shobokshi.  Arab J. Lab. Med. (2003), Vol. 29, No. 3: 427-434

 

7.      Maternal Plasma Fetal DNA Level in Hyperemesis Gravidarun and its Relationship to the Severity of the Disease. Amal S. Shobokshi.
Arab J. Lab. Med. (2003), Vol. 29, No. 3: 437-443

 

8.    Biomarkers of Endometrial Receptivity. Amal S. Shobokshi. The Arab Journal of Laboratory Medicine. 2003, Vol. 29, No. 2: pp 269-282

 

    9.      Gene Mutations Patients with Reproductive Disorders.  Amal S.  ٍٍٍShobokshi.   The Arab Journal of Laboratory Medicine. 2003,   Vol. 29, No. 3: pp 321-335.

 

10.      Correction of Insulin Resistance and Hyperandrogenism in Polycystic Ovary Syndrome By Combined Rosiglitazone and Clomiphene Citrate Therapy”.  Amal Shobokshi and Mohamed ShaarawyJ Soc Gynecol Investig Vol. 10, No. 2, February 2003.

 

11.      Expression of P16ink4a in Cervical Dysplasia”. Tarek A. H. El-Dessouk and  Amal S. Shobokshi.(Accepted for Publication), Ain Shams Medical Journal.

 

12.      Cyclin D1 and Cell-cycle-dependent kinase inhibitors as Prognostic
Parameters in epithelial Ovarian Carcinomas.
Amal S. Shobokshi
and
Tarek A. H. El-Dessouki(Accepted for Publication), Ain Shams Medical Journal.

 

13.      Diversity of Endometrioid Carcinoma.  Tarek A. H. El-Dessouki and
Amal S. Shobokshi.
 (Accepted for Publication), Egyptian Society for Obstetric and Gynecology.

 

14.   Cervical mucus granulocyte macrophage colony stimulating factor and interleukin-2 soluble receptor in women using copper intrauterine contraceptivedevices. A. Shobokshi, and M.Shaarawy.
Contraception 66 (2002) 129-132

 

15. Serum Angiogenin and CA125 in Hyperplastic and malignant Endometrium. Mohamed Shaarawy and  Amal Shobokshi.
Cancer Research Therapy Control, 2002, Vol. 11(3-4), pp. 241-248.

 

16.     Maternal serum and amniotic fluid cytokines in patients with preterm
premature rupture of membranes with and without intrauterine infection.  
A. Shobokshi, and M. Shaarawy.  International Journal of Gynecology and Obstetrics 79 (2002) 209-215.

 

 

17.      The Clinical Value of Detecting Extracellular Domain of C-reb B-2
Oncoprotein P53 Tumor Suppressor Gene Mutant Protein Hyperplastic and Malignant Endometrium”.
Mohamed Shaarawy and
Amal Shobokshi. Cancer Research Therapy Control, 2001, Vol. 11, pp. 89-97.

 

18.  Morphologic Study of Abortus in Chromosomally Abnormal Pregnancy. Tarek A. H. El-Dessouki and Amal S. Shobokshi.  Ain Shams Medical Journal. Vol. 52, No. 1,2&3 (2001)

 

 

19. Abdominal Myomectomy Versus Abdominal Hysterectomy for Symptomatic and Big Uterine Fibroids.  Abdulrahim A. Rouzi, Afaf I. Al-Noury, Amal S. Shobokshi, Hassan Jamal and Hassan. Abduljabbar. Saudi Medical Journal 2001; Vol. 22(11): 984-986.